Please use this identifier to cite or link to this item:
|Title:||Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors||Authors:||Koo, C.-Y.
Phyllodes tumor grade
|Issue Date:||21-Oct-2006||Citation:||Koo, C.-Y., Bay, B.-H., Lui, P.C.-W., Tse, G.M.-K., Tan, P.-H., Yip, G.W.-C. (2006-10-21). Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors. Modern Pathology 19 (10) : 1344-1350. ScholarBank@NUS Repository. https://doi.org/10.1038/modpathol.3800657||Abstract:||Phyllodes tumors are fibroepithelial neoplasms typified by stromal proliferation. We have previously shown the role of pathologic parameters and the prognostic significance of p53 and CD117 protein expression in these tumors. In this study, we evaluated the expression of heparan sulfate, which has been implicated in many biological processes such as cell adhesion, embryogenesis, and tumorigenesis (including malignant transformation of mammary cells) in 232 breast phyllodes tumors. We used a monoclonal antibody, 10E4, to examine the localization of heparan sulfate in phyllodes tumors by immunohistochemistry. The immunoreactivity of both epithelial and stromal components was examined and analyzed with pathological parameters and other immunohistochemical markers, including p53, MIB1, bcl2, and CD117. Stromal 10E4 expression was significantly associated with tumor grade, stromal p53, and MIB1 expression in proliferating cells, suggesting that heparan sulfate may participate in malignant tumor growth. © 2006 USCAP, Inc. All rights reserved.||Source Title:||Modern Pathology||URI:||http://scholarbank.nus.edu.sg/handle/10635/120679||ISSN:||08933952||DOI:||10.1038/modpathol.3800657|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 24, 2021
WEB OF SCIENCETM
checked on Feb 16, 2021
checked on Feb 13, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.